Keyphrases
Conventional Chemotherapy
100%
Peritoneal Carcinomatosis
100%
Cancer-related
50%
Combination Chemotherapy
50%
Median Survival
33%
Biologic Therapy
33%
Patients with Colorectal Cancer
33%
Colorectal Cancer
16%
Improved Outcomes
16%
Tumor
16%
Biological Agents
16%
Treatment Regimen
16%
Historical Cohort
16%
Therapeutic Adjuncts
16%
Patient Selection
16%
Survival Data
16%
Survival Curve
16%
Survival Disparities
16%
Secondary Cytoreductive Surgery
16%
Metastatic Colorectal Cancer (mCRC)
16%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
16%
Medicine and Dentistry
Colorectal Carcinoma
100%
Combination Chemotherapy
100%
Carcinomatous Peritonitis
100%
Biological Therapy
66%
Neoplasm
33%
Hyperthermic Intraperitoneal Chemotherapy
33%
Metastatic Colorectal Cancer
33%
Diseases
33%
Nursing and Health Professions
Carcinomatous Peritonitis
100%
Combination Chemotherapy
100%
Colorectal Carcinoma
100%
Biological Therapy
66%
Neoplasm
33%
Hyperthermic Intraperitoneal Chemotherapy
33%
Metastatic Colorectal Cancer
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Carcinomatous Peritonitis
100%
Colorectal Carcinoma
33%
Neoplasm
11%
Metastatic Colorectal Cancer
11%
Intraperitoneal Chemotherapy
11%
Diseases
11%